ANIXA BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
ANIXA BIOSCIENCES, INC. (ANIX) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $4.31 million as of 2017-01-31, per its 10-Q filed 2017-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2018-01-09
- 2017-01-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.31M.
- 2016-10-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.17M.
- 2016-07-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.07M.
- 2016-04-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $3.94M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2017-01-31 | $4.31M 10-Q · filed 2017-03-16 |
| 2016-10-31 | $4.17M 10-K · filed 2018-01-09 |
| 2016-07-31 | $4.07M 10-Q · filed 2016-08-19 |
| 2016-04-30 | $3.94M 10-Q · filed 2016-05-20 |
| 2016-01-31 | $3.81M 10-Q · filed 2016-02-19 |
| 2015-10-31 | $3.69M 10-K · filed 2018-01-09 |
| 2015-07-31 | $3.57M 10-Q · filed 2015-08-18 |
| 2015-04-30 | $3.45M 10-Q · filed 2015-05-22 |
| 2015-01-31 | $3.35M 10-Q · filed 2015-03-09 |
| 2014-10-31 | $3.24M 10-K · filed 2016-12-08 |
| 2014-07-31 | $1.90K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $5.79M 10-Q · filed 2014-06-16 |
| 2013-10-31 | $540.00K 10-Q · filed 2014-09-15 |
| 2013-01-31 | $1.18M 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |